Increased SARS-CoV-2 reactive low avidity T cells producing inflammatory cytokines in pediatric post-acute COVID-19

Krystallenia Paniskaki1,2, Sarah Goretzki1,3, Moritz Anft2

  • 1Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Insights

Children with post-acute COVID-19 sequelae (PASC) show persistent SARS-CoV-2 specific T-cell responses, suggesting cellular inflammation may drive long COVID symptoms in pediatrics. Further research is needed for therapeutic strategies.

Area of Science:

  • Immunology
  • Pediatric Infectious Diseases
  • Viral Sequelae

Background:

  • A subset of pediatric COVID-19 survivors experience persistent symptoms resembling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID.
  • Clinical data and immune mechanisms underlying these pediatric post-acute COVID-19 sequelae (PASC) are not well understood.

Purpose of the Study:

  • To comprehensively profile the clinical and immunological characteristics of children with PASC.
  • To compare immune responses between children with and without PASC.

Main Methods:

  • Clinical assessment including medical history, physical examination, and laboratory tests.
  • Analysis of SARS-CoV-2 specific T-cell responses (CD4+ and CD8+) using multiparametric flow cytometry.
  • Assessment of humoral immunity via pseudovirus neutralization and ELISA assays.

Main Results:

  • Common PASC symptoms included shortness of breath, exercise intolerance, paresthesia, smell/taste disturbance, chest pain, dyspnea, headache, and lack of concentration.
  • Elevated frequencies of SARS-CoV-2 spike (S) reactive CD4+ and CD8+ T cells with TNFα and IFNγ production and low functional avidity were observed in the PASC group.
  • C-reactive protein (CRP) levels positively correlated with IFNγ-producing reactive CD8+ T cells.

Conclusions:

  • Findings suggest a potential role for persistent SARS-CoV-2 triggered cellular inflammation in the development of pediatric PASC.
  • These insights may inform future therapeutic and preventive strategies for long COVID in children.
Abstract